Recent talks with the team

Sara Van Driest putting the "omics" in Pharmacogenomics: Here

A Brief Introduction to the Lab

Our active research projects include searching for pharmacogenomic signals in pediatric patients, developing methods to identify latent drug effects using electronic health records data, studying fentanyl pharmacokinetics and pharmacodynamics, and defining the genomic architecture of pharmacogenomic traits. Funding for our research work comes from the National Institutes of Health (NIH) institutes of Child Health and Human Development (NICHD), General Medical Sciences (NIGMS), and Human Genome Research (NHGRI). Dr. Van Driest also was awarded an early career award from the PhRMA Foundation, an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund, and a Doris Duke Clinical Scientist Development Award.